Navigation Links
Greeks get space-based help in wake of deadly fires
Date:10/5/2007

Cleanup and rebuilding teams responding to the devastation across Greece caused by this summers deadly fires are getting help from space. A series of crisis map products based on satellite acquisitions of affected areas are being provided to aid damage assessment efforts following the activation of the International Charter on Space and Major Disasters.

More than 60 people were killed and thousands left homeless in the worst forest fires to hit Greece in decades. According to data from ESAs ERS-2 and Envisat satellites, which continuously survey fires burning across the Earths surface with onboard sensors, Greece experienced more wildfire activity this August than other European countries experienced over the last decade.

In an effort to aid authorities responding to disasters such as this, ESA and other national space agencies established the International Charter on Space and Major Disasters in 2000 to provide rush access to a broad range of satellite data.

The Charter, activated by the Department of Emergency Planning and Response of the Greek Civil Protection Agency, processed this request and recruited the German Aerospace Centre (DLR) and the Strasbourg-based rapid mapping specialist company (SERTIT) to produce the maps using satellite images provided by the space agencies.

As a result, the Greek Civil Protection Agency received a series of Earth Observation (EO)-based crisis/damage mapping products generated using a variety of EO sensors. The first EO-based maps, delivered while the fires were still active, were overview products based on the Medium Resolution Imaging Spectrometer (MERIS) instrument aboard ESAs Envisat satellite. French and German Civil Protections active in Greece to support fire fighting teams also received the maps.

These maps were used for fighting active fires across Greece, particularly those in the region of the Parnonas Mountains, which rise to almost 2000 metres on the eastern side of
'/>"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-069-418-0856
European Space Agency
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Metavante fires 180 North American workers
2. IT wildfires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic disease, today announced the next step in its ... bio-analytics solutions provider with the naming of current Chief ... Chief Executive Officer, while current Chairman of the Board ... serve as Chairman. These changes are effective January 1, ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... Capital Investments,Inc. (AMEX: MGT ), a technology ... sector, today reported financial results,for the first quarter ... on,strategic milestones., Tim Paterson-Brown, MGT Chairman and ... turning point for our subsidiaries, Medicsight and,Medicexchange. In ...
... Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today ... Rodman & Renshaw 5th Annual Global,Healthcare Conference on Tuesday, ... Beach Plaza Hotel in Monte Carlo, Monaco., The ... be,accessed under "Calendar of Events" in the Idenix Investor ...
... MedQuist Inc.,(Pink Sheets: MEDQ), the largest Medical Transcription Service ... its Form 10-Q quarterly,report with the U.S. Securities and ... Revenue for the first quarter of 2008 was $83.7M ... decrease in revenue of $5.4M or 6% from,the prior ...
Cached Biology Technology:MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4MedQuist Reports First Quarter 2008 Results 2MedQuist Reports First Quarter 2008 Results 3MedQuist Reports First Quarter 2008 Results 4MedQuist Reports First Quarter 2008 Results 5MedQuist Reports First Quarter 2008 Results 6MedQuist Reports First Quarter 2008 Results 7MedQuist Reports First Quarter 2008 Results 8MedQuist Reports First Quarter 2008 Results 9
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... 4, 2014  Tute Genomics, a leader in cloud-based ... Series A1 funding led by UK-based Eurovestech. Peak Ventures ... the investment round. "We are at a ... next-generation sequencing and seeks new approaches for the diagnosis, ... , MD MBA, and CEO of Tute Genomics. "One ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... a Tiger,s feet were built the same way as a mongoose,s ... feet to support the big cat,s weight. But they,re not. ... feet are put together across the four-legged animal kingdom, but until ... of the foot that bear the brunt of the animal,s walking ...
... advance toward scavenging energy from walking, breathing, and other ... phones and heart pacemakers. In a study in ACS, ... of flexible, biocompatible rubber films for use in implantable ... used, for instance, to harvest energy from the motion ...
... research suggests that nitric oxide may play a role in ... Mittal et al, "Inhibition of inducible nitric oxide controls pathogen ... coli K1 in neonatal meningitis," appears in the March ... Bacterial meningitis, or inflammation of the membranes that ...
Cached Biology News:The bigger the animal, the stiffer the 'shoes' 2Treating neonatal meningitis -- is nitric oxide a foe or a friend to bacteria? 2
MHC Volumes 1 & 2...
...
... Johnstone and M.W. Turner (1997). • ... methods used in the production of ... in immunoassays, the standardisation of antibodies ... including amplification systems, enzyme immunoassays for ...
... PAGE Cleavable ICAT Reagent ... Protein ID and Quantitation ... Electrophoresis (PAGE), isotope-coded affinity ... technology to facilitate the ...
Biology Products: